55%
Growth in switch rate
13X
Higher retention
Empowering MS Patients in Canada
MS is a chronic disease that affects each person differently, and patients often face many challenges and concerns about their treatment options and lifestyle changes. To effectively connect, educate and support their main target audience in Canada, a leading healthcare company known for manufacturing a groundbreaking B-Cell therapy for MS patients, partnered with Belong.life.
Tackling Patient Challenges with an Innovative Patient Support Program
Belong launched a Patient Support Program (PSP) with the brand, combined with an awareness campaign in the BelongMS app, to provide a solution for users of their medication who require care, education, and support. The PSP consisted of a care platform that offered peer-to-peer support, personalized information, and guidance to patients throughout their treatment journey. It also included a tracker designed to monitor their disease activity.
Outstanding Success in Less Than a Year: Key Metrics Revealed
Here are some of the critical metrics that demonstrated the success of the PSP in less than a year:
- High Reach – The number of registered users on the care platform totaled 20% of the MS population in Canada.
- High Engagement – The retention rate is 13X higher than the industry benchmark, and users spend 2.5X more time in the app per quarter than the average user.
- Positive influence – 75% of the therapy mentions among patients taking it were either positive or neutral.
- Increase in discussion – The number of conversations about the therapy on the BelongMS open platform increased by 109% since the closed communities were launched, and 35.2% of them were initiated by users from the PSP.
- Conversions – The switching rate to the therapy in the BelongMS app increased by 55% compared to the market.
Improving the lives of people with MS
The PSP played a crucial role in the B-Cell therapy success in Canada. It helped to differentiate itself from other MS therapies by offering a personalized experience. It also created a community of highly engaged users who advocated for the therapy. Building the community helped MS patients feel less alone, more supported and demonstrated the company’s commitment to improving the lives of people with MS.
Want to learn how to build a successful patient care platform? Reach out to us here for insights and guidance.
